ETRACS 2x Leveraged MSCI US Quality Factor TR ETN
QULL
1 hedge funds and large institutions have $3.63K invested in ETRACS 2x Leveraged MSCI US Quality Factor TR ETN in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0.08% less ownership
Funds ownership: 0.09% → 0.01% (-0.08%)
86% less capital invested
Capital invested by funds: $26.5K → $3.63K (-$22.9K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$25.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $3.63K | -$25.9K | -832 | -89% |
|
QULL Hedge Fund Activity: Q4 2023 in Review
1 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL) for Q4 2023, worth a combined $3.63K — down 86% from $26.5K a quarter earlier.
Fund positioning in QULL was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $25.9K.
- 1 institutional investor held ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $3.63K of ETRACS 2x Leveraged MSCI US Quality Factor TR ETN stock for Q4 2023, down 86% quarter-over-quarter.
- 0 funds opened new ETRACS 2x Leveraged MSCI US Quality Factor TR ETN positions in Q4 2023 and 0 closed out.
- The largest ETRACS 2x Leveraged MSCI US Quality Factor TR ETN seller in Q4 2023 was UBS Group, an estimated $25.9K sold.
Based on aggregated 13F filings for Q4 2023.